Login to Your Account



Proximagen Sells Clinical-Stage Compound in $51M Deal

By Catherine Hollingsworth


Thursday, August 5, 2010
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription